Global Implantable Neuromodulation Device 麻豆原创 Research Report 2024

Publication ID:

PB508241702

Publication Date:

August 9, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Neuromodulation devices are听advanced medical tools that can increase or decrease the activity of the nervous system. Research has found this technology may be effective in reducing migraine attacks and cluster headaches.
The global Implantable Neuromodulation Device market was valued at US$ 3056.2 million in 2023 and is anticipated to reach US$ 3734.4 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
The Implantable Neuromodulation Device market was growing due to advancements in medical technology and increasing applications of neuromodulation therapies for various medical conditions. Implantable neuromodulation devices are medical devices that deliver targeted electrical or chemical stimulation to specific nerves or areas of the nervous system to treat chronic pain, neurological disorders, and other conditions.
This report aims to provide a comprehensive presentation of the global market for Implantable Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neuromodulation Device.
Report Scope
The Implantable Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Implantable Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Implantable Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Implantable Neuromodulation Device 麻豆原创 Overview
1.1 Product Overview and Scope of Implantable Neuromodulation Device
1.2 Implantable Neuromodulation Device Segment by Type
1.2.1 Global Implantable Neuromodulation Device 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Gastric Stimulation
1.2.5 Transcranial Magnetic Stimulation
1.2.6 Transcutaneous Electrical Stimulation
1.2.7 Other
1.3 Implantable Neuromodulation Device Segment by Application
1.3.1 Global Implantable Neuromodulation Device 麻豆原创 Value by Application: (2024-2030)
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Implantable Neuromodulation Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Implantable Neuromodulation Device Revenue 2019-2030
1.4.2 Global Implantable Neuromodulation Device Sales 2019-2030
1.4.3 Global Implantable Neuromodulation Device 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Implantable Neuromodulation Device 麻豆原创 Competition by Manufacturers
2.1 Global Implantable Neuromodulation Device Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Implantable Neuromodulation Device Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Implantable Neuromodulation Device Average Price by Manufacturers (2019-2024)
2.4 Global Implantable Neuromodulation Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Implantable Neuromodulation Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Implantable Neuromodulation Device, Product Type & Application
2.7 Implantable Neuromodulation Device 麻豆原创 Competitive Situation and Trends
2.7.1 Implantable Neuromodulation Device 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Implantable Neuromodulation Device Players 麻豆原创 Share by Revenue
2.7.3 Global Implantable Neuromodulation Device 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Implantable Neuromodulation Device Retrospective 麻豆原创 Scenario by Region
3.1 Global Implantable Neuromodulation Device 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Implantable Neuromodulation Device Global Implantable Neuromodulation Device Sales by Region: 2019-2030
3.2.1 Global Implantable Neuromodulation Device Sales by Region: 2019-2024
3.2.2 Global Implantable Neuromodulation Device Sales by Region: 2025-2030
3.3 Global Implantable Neuromodulation Device Global Implantable Neuromodulation Device Revenue by Region: 2019-2030
3.3.1 Global Implantable Neuromodulation Device Revenue by Region: 2019-2024
3.3.2 Global Implantable Neuromodulation Device Revenue by Region: 2025-2030
3.4 North America Implantable Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Implantable Neuromodulation Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Implantable Neuromodulation Device Sales by Country (2019-2030)
3.4.3 North America Implantable Neuromodulation Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Implantable Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Implantable Neuromodulation Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Implantable Neuromodulation Device Sales by Country (2019-2030)
3.5.3 Europe Implantable Neuromodulation Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Implantable Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Implantable Neuromodulation Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Implantable Neuromodulation Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Implantable Neuromodulation Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Implantable Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Implantable Neuromodulation Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Implantable Neuromodulation Device Sales by Country (2019-2030)
3.7.3 Latin America Implantable Neuromodulation Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Implantable Neuromodulation Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Implantable Neuromodulation Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Implantable Neuromodulation Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Implantable Neuromodulation Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Implantable Neuromodulation Device Sales by Type (2019-2030)
4.1.1 Global Implantable Neuromodulation Device Sales by Type (2019-2024)
4.1.2 Global Implantable Neuromodulation Device Sales by Type (2025-2030)
4.1.3 Global Implantable Neuromodulation Device Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Implantable Neuromodulation Device Revenue by Type (2019-2030)
4.2.1 Global Implantable Neuromodulation Device Revenue by Type (2019-2024)
4.2.2 Global Implantable Neuromodulation Device Revenue by Type (2025-2030)
4.2.3 Global Implantable Neuromodulation Device Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Implantable Neuromodulation Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Implantable Neuromodulation Device Sales by Application (2019-2030)
5.1.1 Global Implantable Neuromodulation Device Sales by Application (2019-2024)
5.1.2 Global Implantable Neuromodulation Device Sales by Application (2025-2030)
5.1.3 Global Implantable Neuromodulation Device Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Implantable Neuromodulation Device Revenue by Application (2019-2030)
5.2.1 Global Implantable Neuromodulation Device Revenue by Application (2019-2024)
5.2.2 Global Implantable Neuromodulation Device Revenue by Application (2025-2030)
5.2.3 Global Implantable Neuromodulation Device Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Implantable Neuromodulation Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Implantable Neuromodulation Device Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Implantable Neuromodulation Device Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Boston Scientific Corporation
6.3.1 Boston Scientific Corporation Corporation Information
6.3.2 Boston Scientific Corporation Description and Business Overview
6.3.3 Boston Scientific Corporation Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boston Scientific Corporation Implantable Neuromodulation Device Product Portfolio
6.3.5 Boston Scientific Corporation Recent Developments/Updates
6.4 St. Jude Medical
6.4.1 St. Jude Medical Corporation Information
6.4.2 St. Jude Medical Description and Business Overview
6.4.3 St. Jude Medical Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 St. Jude Medical Implantable Neuromodulation Device Product Portfolio
6.4.5 St. Jude Medical Recent Developments/Updates
6.5 Synapse Biomedical
6.5.1 Synapse Biomedical Corporation Information
6.5.2 Synapse Biomedical Description and Business Overview
6.5.3 Synapse Biomedical Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Synapse Biomedical Implantable Neuromodulation Device Product Portfolio
6.5.5 Synapse Biomedical Recent Developments/Updates
6.6 Nevro Corporation
6.6.1 Nevro Corporation Corporation Information
6.6.2 Nevro Corporation Description and Business Overview
6.6.3 Nevro Corporation Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nevro Corporation Implantable Neuromodulation Device Product Portfolio
6.6.5 Nevro Corporation Recent Developments/Updates
6.7 Neuropace
6.6.1 Neuropace Corporation Information
6.6.2 Neuropace Description and Business Overview
6.6.3 Neuropace Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Neuropace Implantable Neuromodulation Device Product Portfolio
6.7.5 Neuropace Recent Developments/Updates
6.8 Cyberonics
6.8.1 Cyberonics Corporation Information
6.8.2 Cyberonics Description and Business Overview
6.8.3 Cyberonics Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cyberonics Implantable Neuromodulation Device Product Portfolio
6.8.5 Cyberonics Recent Developments/Updates
6.9 Autonomic Technologies
6.9.1 Autonomic Technologies Corporation Information
6.9.2 Autonomic Technologies Description and Business Overview
6.9.3 Autonomic Technologies Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Autonomic Technologies Implantable Neuromodulation Device Product Portfolio
6.9.5 Autonomic Technologies Recent Developments/Updates
6.10 Avery Biomedical
6.10.1 Avery Biomedical Corporation Information
6.10.2 Avery Biomedical Description and Business Overview
6.10.3 Avery Biomedical Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Avery Biomedical Implantable Neuromodulation Device Product Portfolio
6.10.5 Avery Biomedical Recent Developments/Updates
6.11 Greatbatch Medical
6.11.1 Greatbatch Medical Corporation Information
6.11.2 Greatbatch Medical Implantable Neuromodulation Device Description and Business Overview
6.11.3 Greatbatch Medical Implantable Neuromodulation Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Greatbatch Medical Implantable Neuromodulation Device Product Portfolio
6.11.5 Greatbatch Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Implantable Neuromodulation Device Industry Chain Analysis
7.2 Implantable Neuromodulation Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Implantable Neuromodulation Device Production Mode & Process
7.4 Implantable Neuromodulation Device Sales and 麻豆原创ing
7.4.1 Implantable Neuromodulation Device Sales Channels
7.4.2 Implantable Neuromodulation Device Distributors
7.5 Implantable Neuromodulation Device Customers
8 Implantable Neuromodulation Device 麻豆原创 Dynamics
8.1 Implantable Neuromodulation Device Industry Trends
8.2 Implantable Neuromodulation Device 麻豆原创 Drivers
8.3 Implantable Neuromodulation Device 麻豆原创 Challenges
8.4 Implantable Neuromodulation Device 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Medtronic
Abbott
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.